PATENT CLAIM ANALYSIS

Application Number: 16226175
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["424", "153100"]

Abstract:
The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.

Claim (Index 35):
The method of  claim 34 , wherein the pharmaceutically acceptable salt is selected from chloride, phosphate, lactate, tartrate, maleate, fumarate, methanesulfonate, and pamoate.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524844', '15113154', '15213829', '15645544', '14771817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.760493256194902
- 35 USC 102 Novelty (BERT): 0.5957962822266621
- Combined Prediction Score: 0.7440235587980781
- Mean Citation Score: 346.191074
- Max Citation Score: 630.56506
- Similarity Product: 412.5296547303569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test